DXN Holdings Bhd. (KLSE:DXN)

Malaysia · Delayed Price · Currency is MYR

0.4750

+0.0050 (1.06%)

At close: Jul 20, 2026

-5.94% (1Y)

Market Cap	2.34B -6.9%
Revenue (ttm)	1.93B -0.3%
Net Income	271.52M -17.2%
EPS	0.05 -17.2%
Shares Out	4.97B
PE Ratio	8.61
Forward PE	7.40
Dividend	0.03 (6.74%)
Ex-Dividend Date	May 13, 2026

Volume	1,557,500
Open	0.4700
Previous Close	0.4700
Day's Range	0.4700 - 0.4750
52-Week Range	0.4250 - 0.5500
Beta	0.22
Analysts	Buy
Price Target	0.58 (+22.11%)
Earnings Date	May 29, 2026

About DXN Holdings Bhd.

DXN Holdings Bhd. manufactures and sales health supplements and other products on direct sales basis in Latin America, Malaysia, Asia, North America, Africa, Europe, the Middle East, and Oceania. It offers coffee, tea, nutritious drinks, juices, confectionery and biscuits, herbs, mushrooms and fungi, premixes, toothpastes, face masks, perfumes, body foams, shampoos, soaps, powders, travel kits, toothbrushes, sanitizers, massage and baby oil, lipsticks, finish powders, and scrubs. The company also operates cafes, glamping resort, tourism village... [Read more]

Industry Pharmaceutical Preparations

Founded 1993

Employees 3,805

Stock Exchange Bursa Malaysia

Ticker Symbol DXN

Full Company Profile

Financial Performance

In fiscal year 2026, DXN Holdings Bhd.'s revenue was 1.93 billion, a decrease of -0.30% compared to the previous year's 1.94 billion. Earnings were 271.52 million, a decrease of -17.24%.

Financial Statements

Analyst Summary

According to 3 analysts, the average rating for DXN stock is "Buy." The 12-month stock price target is RM 0.58, which is an increase of 22.11% from the latest price.

Price Target

RM 0.58

(22.11% upside)

Analyst Consensus: Buy

Stock Forecasts